Stay updated on ONCOS-102 Combo ImmunoTx in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the ONCOS-102 Combo ImmunoTx in Advanced Melanoma Clinical Trial page.

Latest updates to the ONCOS-102 Combo ImmunoTx in Advanced Melanoma Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRecord history now includes Revision v3.3.2 and no longer lists Revision v3.2.0.SummaryDifference0.1%

- Check38 days agoChange DetectedRemoved the government funding/operating status banner from the page; the banner warned about potential delays in updates, but the core study information remains unchanged.SummaryDifference0.8%

- Check52 days agoChange DetectedNew and revised versions show updates to Study Identification, Study Status, Outcome Measures, Recruitment Status, and Study Design. These changes reflect updates to the trial’s core metadata, status, and Contacts/Locations.SummaryDifference0.1%

- Check81 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference13%

- Check88 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.3%

Stay in the know with updates to ONCOS-102 Combo ImmunoTx in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ONCOS-102 Combo ImmunoTx in Advanced Melanoma Clinical Trial page.